Genzyme buys into Brit firm<\/p>\n
Genzyme intends to invest $37.7 million in a British company as part of an alliance to develop treatments for such diseases as scleroderma and rheumatic diseases.<\/p>\n
Under the agreement with Cambridge Antibody Technology Group, Genzyme will buy an 11 percent stake in the company, giving it much- needed cash. – STAFF<\/p>\n
Verizons OK portability<\/p>\n
Verizon Communications and Verizon Wireless, a unit of the phone giant, have reached an agreement that would allow customers to keep their old phone numbers if they switch from a wireless service to home service, and vice versa, the companies said yesterday. – STAFF<\/p>\n
Centers expand work<\/p>\n
Beth Israel Deaconess Medical Center and Joslin Diabetes Center announced a five-year agreement yesterday that expands their clinical collaboration In addition to strengthening diabetes treatment and education programs, the two will create clinical guidelines and interactive programs for those with the disease. – STAFF<\/p>\n
Trust goes shopping<\/p>\n
Boston-based Heritage Property Investment Trust Inc. has agreed to buy seven Texas shopping centers and one in Mississippi from Trademark Property Co. for $160 million. – STAFF<\/p>\n
Evergreen taps CEO<\/p>\n
Evergreen Investments said yesterday that its chief investment officer, Dennis Ferro, will also be its chief executive. Ferro replaces Bill Ennis, who left Evergreen, an asset-management arm of Wachovia Corp., earlier this year. Ferro will be based in Evergreen’s Charlotte, N.C., office but will also work at the firm’s Boston office, a spokeswoman said. – STAFF<\/p>\n
Complaint hits fund<\/p>\n
Secretary of State William Galvin issued a complaint against a Hingham man yesterday for selling stakes in an unregistered hedge fund in which certain clients lost most of their money. Galvin is asking for the denial of a license application of Gerald Stonehouse, a former broker in the Norwell office of Wachovia Securities, and a fine.<\/p>\n
Galvin has filed a complaint against the hedge fund, Futronix Futures Fund, and its manager. – STAFF<\/p>\n
Dispute reaches tube<\/p>\n
NEW YORK – Reporters for The Wall Street Journal and other Dow Jones & Co. publications began a monthlong boycott yesterday of voluntary appearances on CNBC in an escalating labor dispute over health-care benefits. – AP<\/p>\n","protected":false},"excerpt":{"rendered":"
Genzyme buys into Brit firm Genzyme intends to invest $37.7 million in a British company as part of an alliance to develop treatments for such diseases as scleroderma and rheumatic diseases. Under the agreement with Cambridge Antibody Technology Group, Genzyme […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-1154","post","type-post","status-publish","format-standard","hentry","category-hedgeco-news"],"_links":{"self":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/1154","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/comments?post=1154"}],"version-history":[{"count":0,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/1154\/revisions"}],"wp:attachment":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/media?parent=1154"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/categories?post=1154"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/tags?post=1154"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}